Maestas Nicholas has filed 5 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 140000 shares of Tempest Therapeutics, Inc. ($TPST) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Tempest Therapeutics, Inc. | $TPST | Maestas Nicholas | Chief Financial Officer | A | Employee Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 4,440,161 | 9999.99% | 3.15% |
| Jan. 2, 2025 | Tempest Therapeutics, Inc. | $TPST | Maestas Nicholas | Chief Financial Officer | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Tempest Therapeutics, Inc. | $TPST | Maestas Nicholas | VP of Strategy and Finance | A | Employee Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2023 | Tempest Therapeutics, Inc. | $TPST | Maestas Nicholas | VP of Strategy and Finance | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Tempest Therapeutics, Inc. | $TPST | Maestas Nicholas | VP of Strategy and Finance | A | Employee Stock Option (right to buy) | 38425 | $0.00 | 38,425.0000 | 0 | 9999.99% | 0.00% |